Overview

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplant may be able to replace immune cells that were destroyed by chemotherapy. PURPOSE: This phase II trial is studying how well combination chemotherapy regimens with or without radiation therapy or peripheral stem cell transplant works in treating children with Hodgkin's lymphoma.

Phase:

Phase 2

Details

Lead Sponsor:

Children's Cancer and Leukaemia Group

Treatments:

Bleomycin
Chlorambucil
Dacarbazine
Doxorubicin
Etoposide
Ifosfamide
Liposomal doxorubicin
Melphalan
Prednisolone
Procarbazine
Vinblastine
Vincristine